Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Amphotericin B/potassium chloride/sulfadiazine

Haemolytic anaemia, acute renal failure and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Suryawanshi VR, et al. A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy Associated Adverse Drug Reactions in a Patient Newly Co-diagnosed with Acquired Immune Deficiency Syndrome. Current Drug Safety 18: 393-397, No. 3, 2023. Available from: URL: http://doi.org/10.2174/1574886317666220707144418 Suryawanshi VR, et al. A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy Associated Adverse Drug Reactions in a Patient Newly Co-diagnosed with Acquired Immune Deficiency Syndrome. Current Drug Safety 18: 393-397, No. 3, 2023. Available from: URL: http://​doi.​org/​10.​2174/​1574886317666220​707144418
Metadaten
Titel
Amphotericin B/potassium chloride/sulfadiazine
Haemolytic anaemia, acute renal failure and lack of efficacy: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41700-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Misoprostol

Case report

Urofollitropin

Case report

Pemetrexed